Loading Complete
Amit Mehta

Amit Mehta, MD

Hematologic MalignancyMedical OncologyHematology

Accepting New Patients
Need help scheduling? Call 205-801-9034

Highlights

Age Groups Seen

  • Adults

Languages

  • English

About Amit Mehta

Biography

I am a board certified hematologist and oncologist with special interest in Lymphomas. I am a clinical investigator with special interest in developing "no chemotherapy" approaches for the treatment of Lymphoma. "No chemotherapy" approaches include immunotherapy, CAR-T therapy, immune modulating therapy and targeted therapy. I am principal investigator of innovative clinical trials for the treatment of Lymphomas at UAB.

Faculty Appointment

Professor

Research Interests

Lymphoma (B and T cell Lymphoma)
Cutaneous T cell Lymphoma (CTCL)
Immune Effector Cell Therapy-CAR-T therapy

Awards & Recognition

Associate Director, Hematology and Oncology fellowship program
Assistant Director, Phase I program, UAB Comprehensive Cancer Center
Co-Director, Immune Effector Cell therapy program (Chimeric antigen receptor (CAR-T) program, UAB-Bone Marrow Transplant Program.
Co-Director, Cutaneous T cell Lymphoma (CTCL) Clinic, The Kirklin Clinic, Hem/Onc,
Director/Principal Investigator, Lymphoma Tissue Bank, Division of Hem/Onc, UAB CCC
Director- UAB Lymphoma Working Group

Memberships

American Society of Clinical Oncology
American Society of Hematology

Locations

  1. Hematology Oncology at The Kirklin Clinic of UAB Hospital

Expertise

Education

  • Fellowship: University of Alabama Hospital, 2014
  • Residency: George Washington University Hospital, 2011
  • Medical School: Medical College Baroda, 2002

Board Certifications

  • Hematology: American Board of Internal Medicine, 2014
  • Medical Oncology: American Board of Internal Medicine, 2014